MTOR and neoplasm: Vigorous glucose consumption by tumor cells metabolically compete with infiltrating T cells and hyponutrition in T cells reduced mammalian target of rapamycin (mTOR) activity, glycolysis and cytokine production such as interferon (IFN)-γ.